The Agency for Healthcare Research and Quality helped improve health care safety in a country where thousands die of medical ...

From halting diversity programs that benefit disabled workers to making federal staffing cuts, the Trump administration has taken a slew of actions that harm people with disabilities.

CBS reports that roughly 170 workers were laid off from the FDA's Office of Inspections and Investigations. In related FDA news, the pharmaceutical industry is worried about the cuts; layoffs include ...

Modern Healthcare reports that the Senate Budget Committee's proposal includes the House's recommendations that could lead to billions in health program cuts but also provides for greater flexibility.

The Food and Drug Administration had already indicated that it approved the vaccine, but new agency leaders are now requesting more data. Meanwhile, FDA staffers who oversaw expert panel meetings on ...

The Trump administration gave the agency until April 18 to reduce by 35% its spending on contracts. Also, more about the gutting of federal health agencies and how people are responding.

Also: How the push against diversity, equity, and inclusion affects transgender people and those with disabilities; the impact of Trump administration cuts on cancer research; and more.

Since the Trump administration began firing federal workers, they say they feel overwhelmed, have obtained or considered ...

During a day of widespread layoffs, NIH Director Jay Bhattacharya told employees he plans to "implement new policies humanely," while FDA Commissioner Marty Makary touted his "impeccable credentials" ...

AP reports that the attorneys general involved in the lawsuit say the funding cuts will result in “serious harm to public health.” In related news about the Trump administration and DOGE: rural ...

U.S. Attorney General Pam Bondi accused Luigi Mangione, 26 — on trial in the shooting death of UnitedHealthcare CEO Brian Thompson — of committing a "cold-blooded assassination.” President Donald ...

An analysis recently published in JAMA found that the tariffs would likely result in price hikes on a "wide range of medications, from antibiotics to mental health treatments," the lead author said.